Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001301120-25-000035
Filing Date
2025-12-17
Accepted
2025-12-17 19:56:57
Documents
1
Period of Report
2025-12-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1766019414.html 4  
1 FORM 4 wk-form4_1766019414.xml 4 7090
  Complete submission text file 0001301120-25-000035.txt   8629
Mailing Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address
Moreadith Randall (Reporting) CIK: 0001301120 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38519 | Film No.: 251580980

Mailing Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806
Business Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806 (256) 327-9630
Serina Therapeutics, Inc. (Issuer) CIK: 0001708599 (see all company filings)

EIN.: 821436829 | State of Incorp.: AL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)